Mobile Site ›

Test Catalog

Test ID: CHEKS    
CHEK2 Gene, Full Gene Analysis

NY State Approved Indicates the status of NY State approval and if the test is orderable for NY State clients.


Useful For Suggests clinical disorders or settings where the test may be helpful

Evaluation for hereditary susceptibility to breast cancer or Li-Fraumeni-like syndrome


Identification of a familial CHEK2 mutation to allow for predictive testing in family members

Additional Tests Lists test(s) that are always performed, at an additional charge, with the initial test(s)

Test IDReporting NameAvailable SeparatelyAlways Performed
COLDBHereditary Colon Cancer CGH ArrayYes, (order SDEL or HCCD)Yes

Testing Algorithm Delineates situation(s) when tests are added to the initial order. This includes reflex and additional tests.

When this test is ordered, CGH array will always be performed at an additional charge.

Special Instructions and Forms Describes specimen collection and preparation information, test algorithms, and other information pertinent to test. Also includes pertinent information and consent forms to be used when requesting a particular test

Method Name A short description of the method used to perform the test

Polymerase Chain Reaction (PCR) Amplification/DNA Sequencing

(PCR is utilized pursuant to a license agreement with Roche Molecular Systems, Inc.)

Array comparative genomic hybridization (aCGH) is used to test for the presence of large deletions and duplications.

Reporting Name A shorter/abbreviated version of the Published Name for a test; an abbreviated test name

CHEK2 Gene, Full Gene Analysis

Aliases Lists additional common names for a test, as an aid in searching

Li-Fraumeni-Like Syndrome